Liu et al. found that the FPGS rs1544105 polymorphism may affect the treatment outcome of BCP-ALL patients by influencing the expression of FPGS, but the rs1544105 polymorphism was not shown to be associated with any MTX-induced toxicity (Liu et al., 2013). The gene discussed is FPGS; the disease is acute lymphoblastic leukemia.